Design, Synthesis, and Evaluation of Conformationally Constrained Tongs, New Inhibitors of HIV-1 Protease Dimerization
Citations Over TimeTop 10% of 1999 papers
Abstract
The active form of human immunodeficiency virus type 1 protease (HIV-1 PR) is a homodimeric structure in which two subunits are linked through a two-stranded antiparallel beta-sheet consisting of the N- and C-termini of each monomer. To inhibit the dimerization process or disrupt the dimeric interface leading to inactive enzyme, conformationally constrained "molecular tongs" have been designed and synthesized to interfere with one monomer end in a beta-sheet fashion. These molecules are based on two peptidic strands attached to an aromatic scaffold. Inhibitions (submicromolar range) were obtained with molecular tongs containing tripeptidic or tetrapeptidic arms attached to a pyridinediol- or naphthalenediol-based scaffold (Kid = 0.56-4.5 microM at pH 4.7 and 30 degrees C). Kinetic studies are in agreement with an interface inhibition mechanism.
Related Papers
- → Monomer adds to preformed structured oligomers of Aβ-peptides by a two-stage dock–lock mechanism(2006)357 cited
- → Nine Crystal Structures Determine the Substrate Envelope of the MDR HIV-1 Protease(2011)24 cited
- → Models of HIV-1 protease with peptides representing its natural substrates(1998)7 cited
- → Deep recurrent neural networks in HIV-1 protease cleavage classification(2017)3 cited
- → Coarse-Grained Modeling of the HIV–1 Protease Binding Mechanisms: I. Targeting Structural Flexibility of the Protease Flaps and Implications for Drug Design(2009)